Literature DB >> 3653727

Intraoperative use of pure perfluoropropane gas in the management of proliferative vitreoretinopathy.

M Bonnet1, E Santamaria, J Mouche.   

Abstract

A single-step technique for fluid-gas exchange with pure perfluoropropane gas in proliferative vitreoretinopathy (PVR) is described. The technique was used in 38 eyes of 38 patients. Permanent and total retinal reattachment, with a minimum follow-up of 6 months after gas disappearance, was achieved in 24 eyes (63%). The anatomical success rate was 80.9% (17/21 eyes) in PVR grade C and 41% (7/17 eyes) in PVR grade D. Twenty-two of the successful eyes (92%) underwent a single operation. Thirteen of the successful eyes (54%) obtained final visual acuities of 0.1 or better. Severe increase of intraocular pressure postoperatively, due to overestimation of the intraocular space available for gas expansion, is a potential risk of the technique. This risk should be avoided by means of preoperative evaluation of the vitreous cavity volume with A-scan ultrasonography and intraoperative measurement of the intraocular fluid volume displaced by scleral buckling.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653727     DOI: 10.1007/BF02150153

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  Surgical treatment of retinal detachments complicated by proliferative vitreoretinopathy.

Authors:  S de Bustros; R G Michels
Journal:  Am J Ophthalmol       Date:  1984-12-15       Impact factor: 5.258

2.  Expansion of long-acting gas bubbles for intraocular use. Principles and practice.

Authors:  J J Crittenden; E de Juan; J Tiedeman
Journal:  Arch Ophthalmol       Date:  1985-06

3.  Slit-lamp fluid-gas exchange and other office procedures following vitreoretinal surgery.

Authors:  M B Landers; D Robinson; K R Olsen; J Rinkoff
Journal:  Arch Ophthalmol       Date:  1985-07

4.  [Long-lasting expansive gases in the treatment of rhegmatogenous retinal detachment associated with vitreoretinal proliferation].

Authors:  M Bonnet; P Aracil; K Pecoldowa; E Da Col
Journal:  J Fr Ophtalmol       Date:  1985       Impact factor: 0.818

5.  A logical approach to the treatment of massive periretinal proliferation.

Authors:  R Machemer; H Laqua
Journal:  Ophthalmology       Date:  1978-06       Impact factor: 12.079

6.  Perfluorocarbon gases in vitreous surgery.

Authors:  S Chang; H A Lincoff; D J Coleman; W Fuchs; M E Farber
Journal:  Ophthalmology       Date:  1985-05       Impact factor: 12.079

7.  The perfluorocarbon gases in the treatment of retinal detachment.

Authors:  H Lincoff; J Coleman; I Kreissig; G Richard; S Chang; L M Wilcox
Journal:  Ophthalmology       Date:  1983-05       Impact factor: 12.079

8.  The classification of retinal detachment with proliferative vitreoretinopathy.

Authors: 
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

9.  Fluid-gas exchange and photocoagulation after vitrectomy. Indications, technique, and results.

Authors:  M Blumenkranz; T Gardner; G Blankenship
Journal:  Arch Ophthalmol       Date:  1986-02

10.  Perfluoropropane gas in the management of proliferative vitreoretinopathy.

Authors:  S Chang; D J Coleman; H Lincoff; L M Wilcox; R A Braunstein; J M Maisel
Journal:  Am J Ophthalmol       Date:  1984-08-15       Impact factor: 5.258

View more
  3 in total

1.  Contact angles of substances used for internal tamponade in retinal detachment surgery.

Authors:  I M Fawcett; R L Williams; D Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-07       Impact factor: 3.117

2.  Prognostic value of new retinal tears associated with the development of postoperative proliferative vitreoretinopathy.

Authors:  J Fleury; M Bonnet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Intravitreal fluorinated gas preference and occurrence of rare ischemic postoperative complications after pars plana vitrectomy: a survey of the american society of retina specialists.

Authors:  Eric J Sigler; John C Randolph; Steve Charles; Jorge I Calzada
Journal:  J Ophthalmol       Date:  2012-09-11       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.